Back to search
Anaplastic (Malignant) Meningioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anaplastic (Malignant) Meningioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anaplastic (Malignant) Meningioma trials you may qualify forThis study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS)…
The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therap…
The aim of this study is to collect data on activity, toxicity and quality of life of trabectedin therapy in patients with recurrent high-grade meningioma.
Approximately 90% of children with malignant brain tumors that have recurred or relapsed after receiving conventional therapy will die of disease. Despite this…
RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs in chemotherapy, such as ifosfamide, carbo…